Skip to content

HAART interruption safer if CD4 remains above 200

Previously unreported NNRTI psychiatric side-effects come to light

Superinfection with HIV: evidence published

Recent infection with genital herpes increases chances of HIV seroconversion

Cells in foreskin vulnerable to HIV infection

Resistance to AZT can last for over 18 months, even after switch to effective therapy

Glaxo cuts price of HIV drugs for poorest countries

5 million South African AIDS deaths by 2010

China considers public health override of HIV drug patents

Low level of education increases chances of AIDS death in first four months of PI therapy

Study finds d4T use, but not total exposure to NRTIs associated with lipodystrophy

Treating worms cuts HIV viral load

Proportion of heterosexuals infected with subtype B falls in UK

Gonorrhoea is STI most likely to cause HIV rebound in semen of HAART patients

Resistant HIV can remain dominant years after acquisition

AIDS cases fall in European Union

Protease inhibitors impair mitochondrial function: another contributor to HIV lipodystrophy?

Kenyan law changed for cheaper drug imports